In another BiAb, the GPC3/CD3 BiTE was also developed to recruit cytotoxic T lymphocyte (CTL) cells for clearance of GPC3+ HCC cells (Lampen et al., 2018; Table 1 and Figure 1). The gene discussed is GPC3; the disease is hepatocellular carcinoma.